Effects of CGA on renal biochemical markers. by Liping Bao (2936715)

Subjects:

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Authority Groups. by David Vagni (8060432)

Subjects:

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Clarity Groups. by David Vagni (8060432)

Subjects:

Identification of ACADM, ANGPTL4, and NFKB2 as significant predictors of OS in the TCGA-KIRC cohort. by Yu Zhang (12946)

Subjects:

S1 Raw data - by Dominic Michael Rasp (19959412)

Subjects:

S2 Raw data - by Dominic Michael Rasp (19959412)

Subjects:

Summary of HSS and LSI during the LIST. by Dominic Michael Rasp (19959412)

Subjects:

Diagnostic criteria for Alcoholic cardiomyopathy. by Fei Yan (128878)

“…</p><p><b>Results:</b> Globally, ACM burden showed significant declines from 1990 to 2021, with age-standardized rates decreasing by 22.5-37.1% across prevalence, mortality and disability measures. …”

EF-24 induces significant transcriptional changes in K-562 cells. by Ajeet P. Singh (22298432)

Subjects:

Scatterplots of respiratory rate and age by sex. by Ina-Maria Rückert-Eheberg (2824901)

“…</p><p>Results</p><p>Respiratory rate decreased slightly from youngest to middle-aged women and men and increased in old age. …”

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

Tumor volume measurements. by Hedieh Zargaran (21410233)

Prescription data. by Dainty Ei (22265317)

Subjects:

IL-10 levels in tumor lysates post-treatment. by Hedieh Zargaran (21410233)